Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Psychiatry

Shinji Sakamoto, Hiroki Kawai, Yuko Okahisa, Ko Tsutsui, Takashi Kanbayashi, Keiko Tanaka, Yutaka Mizuki, Manabu Takaki, Norihito Yamada

Research output: Contribution to journalReview article

Abstract

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a recently-discovered autoimmune disorder in which antibodies target NMDAR in the brain. The number of reported cases of anti-NMDAR encephalitis has increased rapidly. Anti-NMDAR encephalitis can be mistakenly diagnosed as psychiatric disorders because many patients present with prominent psychiatric symptoms and visit psychiatric institutions first. Thus, psychiatrists should cultivate a better understanding of anti-NMDAR encephalitis. In this review, we present the mechanisms, epidemiology, symptoms and clinical course, diagnostic tests, treatment and outcomes of patients with anti-NMDAR encephalitis. Furthermore, we discuss the diversity of clinical spectra of anti-NMDAR encephalitis, and demonstrate a differential diagnosis of psychiatric disease from the perspective of psychiatry.

Original languageEnglish
Pages (from-to)189-195
Number of pages7
JournalActa medica Okayama
Volume73
Issue number3
DOIs
Publication statusPublished - Jun 1 2019

Fingerprint

Anti-N-Methyl-D-Aspartate Receptor Encephalitis
N-Methyl-D-Aspartate Receptors
Psychiatry
Epidemiology
Routine Diagnostic Tests
Differential Diagnosis
Brain
Antibodies

Keywords

  • encephalitis
  • mood disorder
  • NMDAR
  • psychiatric symptom
  • schizophrenia

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Psychiatry. / Sakamoto, Shinji; Kawai, Hiroki; Okahisa, Yuko; Tsutsui, Ko; Kanbayashi, Takashi; Tanaka, Keiko; Mizuki, Yutaka; Takaki, Manabu; Yamada, Norihito.

In: Acta medica Okayama, Vol. 73, No. 3, 01.06.2019, p. 189-195.

Research output: Contribution to journalReview article

Sakamoto, Shinji ; Kawai, Hiroki ; Okahisa, Yuko ; Tsutsui, Ko ; Kanbayashi, Takashi ; Tanaka, Keiko ; Mizuki, Yutaka ; Takaki, Manabu ; Yamada, Norihito. / Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Psychiatry. In: Acta medica Okayama. 2019 ; Vol. 73, No. 3. pp. 189-195.
@article{a3004dc1cf0a4e61bca529d21bf25041,
title = "Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Psychiatry",
abstract = "Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a recently-discovered autoimmune disorder in which antibodies target NMDAR in the brain. The number of reported cases of anti-NMDAR encephalitis has increased rapidly. Anti-NMDAR encephalitis can be mistakenly diagnosed as psychiatric disorders because many patients present with prominent psychiatric symptoms and visit psychiatric institutions first. Thus, psychiatrists should cultivate a better understanding of anti-NMDAR encephalitis. In this review, we present the mechanisms, epidemiology, symptoms and clinical course, diagnostic tests, treatment and outcomes of patients with anti-NMDAR encephalitis. Furthermore, we discuss the diversity of clinical spectra of anti-NMDAR encephalitis, and demonstrate a differential diagnosis of psychiatric disease from the perspective of psychiatry.",
keywords = "encephalitis, mood disorder, NMDAR, psychiatric symptom, schizophrenia",
author = "Shinji Sakamoto and Hiroki Kawai and Yuko Okahisa and Ko Tsutsui and Takashi Kanbayashi and Keiko Tanaka and Yutaka Mizuki and Manabu Takaki and Norihito Yamada",
year = "2019",
month = "6",
day = "1",
doi = "10.18926/AMO/56860",
language = "English",
volume = "73",
pages = "189--195",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "3",

}

TY - JOUR

T1 - Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Psychiatry

AU - Sakamoto, Shinji

AU - Kawai, Hiroki

AU - Okahisa, Yuko

AU - Tsutsui, Ko

AU - Kanbayashi, Takashi

AU - Tanaka, Keiko

AU - Mizuki, Yutaka

AU - Takaki, Manabu

AU - Yamada, Norihito

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a recently-discovered autoimmune disorder in which antibodies target NMDAR in the brain. The number of reported cases of anti-NMDAR encephalitis has increased rapidly. Anti-NMDAR encephalitis can be mistakenly diagnosed as psychiatric disorders because many patients present with prominent psychiatric symptoms and visit psychiatric institutions first. Thus, psychiatrists should cultivate a better understanding of anti-NMDAR encephalitis. In this review, we present the mechanisms, epidemiology, symptoms and clinical course, diagnostic tests, treatment and outcomes of patients with anti-NMDAR encephalitis. Furthermore, we discuss the diversity of clinical spectra of anti-NMDAR encephalitis, and demonstrate a differential diagnosis of psychiatric disease from the perspective of psychiatry.

AB - Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a recently-discovered autoimmune disorder in which antibodies target NMDAR in the brain. The number of reported cases of anti-NMDAR encephalitis has increased rapidly. Anti-NMDAR encephalitis can be mistakenly diagnosed as psychiatric disorders because many patients present with prominent psychiatric symptoms and visit psychiatric institutions first. Thus, psychiatrists should cultivate a better understanding of anti-NMDAR encephalitis. In this review, we present the mechanisms, epidemiology, symptoms and clinical course, diagnostic tests, treatment and outcomes of patients with anti-NMDAR encephalitis. Furthermore, we discuss the diversity of clinical spectra of anti-NMDAR encephalitis, and demonstrate a differential diagnosis of psychiatric disease from the perspective of psychiatry.

KW - encephalitis

KW - mood disorder

KW - NMDAR

KW - psychiatric symptom

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85068741510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068741510&partnerID=8YFLogxK

U2 - 10.18926/AMO/56860

DO - 10.18926/AMO/56860

M3 - Review article

C2 - 31235965

AN - SCOPUS:85068741510

VL - 73

SP - 189

EP - 195

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 3

ER -